This Solution Provider Archived Webinar is brought to you by DIA in cooperation with Cytel.

The more things change, the more they stay the same - or should they?
 
Modern life science companies are beginning to break free of traditional clinical research constraints that are even today, too often rooted in paper-based anachronisms.  Others will continue to wrestle with “the way it’s always been done” – dependent on obsolete trial conduct training, supervision and data handling practices.

The rise of RBM (Risk-Based Monitoring) is in response partly to the growing concern that monitoring provides little real, demonstrable value.  Despite the vast money and time invested by sponsors, CROs and the sites, trial monitoring’s return on investment at best, is nebulous.

Innovative technology and collaborative product development advancements are already helping clinical trial sponsors and their operations partners to implement transformative approaches based on a more centralized model that better integrates the trial’s design, protocol implementation, monitoring and data collection.

Development strategy experts Laurie Halloran and Irving Dark will paint a very real picture of a new paradigm whereby:

• Monitoring is accomplished remotely through the aid of recent statistical methods
• Patient data is entered directly into a centralized database
• A series of online and in-person, training/performance evaluation visits help ensure site and patent compliance
• We bring new meaning to “real-time data monitoring,” and redefine the very nature of “relationship management.”

Your hosts Laurie and Irving will 1.) Address the growing divide between the sponsor and their clinical research vendors on how best to conduct clinical trials and 2.) Help you distinguish between the “nice to haves” and determine those most critical to your success.

An audience Q&A session will follow their presentation and discussion.

 TO REGISTER FOR THIS EVENT PLEASE CLICK HERE